Teraplast (TRP) Q3 2025 earnings summary

Executive summary

• Consolidated turnover for the first nine months of 2025 reached RON 857.4 million, up 26% year-over-year, driven by volume growth, M&A contributions, and strong demand in Installations and Western markets.

• EBITDA increased by 59% to nearly RON 72 million, with margin improving to 8.4% from 6.6% last year.

• Net profit was RON 6.3 million, reversing a loss of RON 6.9 million in the prior year period, despite non-recurring acquisition expenses.

• Export sales increased 73%, now representing 35% of total turnover, up from 25% a year ago.

Financial highlights

• Turnover: RON 857.4 million (+26% year-over-year).

• EBITDA: RON 71.8 million (+59% year-over-year); EBITDA margin: 8.4% (up from 6.6%).

• Operating profit: RON 29.4 million (+160% year-over-year).

• Gross margin improved to 37% from 35% year-over-year, reaching RON 319.8 million (+33%).

• Exports accounted for 35% of total sales, a significant increase from 2024.

Outlook and guidance

• Focus remains on consolidating recent acquisitions and expanding geographically, especially in less competitive foreign markets.

• M&A will continue selectively, with a preference for international opportunities.

• Ongoing analysis and repositioning of the Teraglass business to improve profitability.

• Ongoing contracts from recent acquisitions are expected to ensure future profitability.

• The group is on track to approach the RON 1 billion turnover milestone, in line with shareholder commitments.